|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.93 CAD | +1.53% |
|
+3.34% | +17.75% |
| 08/07 | Dri Healthcare comments on FDA approval and our increased investment in Kalvista Pharmaceuticals' Ekterly® | RE |
| 02/07 | DRI Healthcare Completes Internalization of Investment Management Division | MT |
| Capitalization | 56Cr 48Cr 45Cr 41Cr 76Cr 4.79TCr 85Cr 531.29Cr 203.07Cr 2.25TCr 209.79Cr 205.41Cr 8.18TCr | P/E ratio 2025 * |
101x | P/E ratio 2026 * | 28x |
|---|---|---|---|---|---|
| Enterprise value | 89Cr 76Cr 71Cr 66Cr 121.52Cr 7.63TCr 134.98Cr 845.23Cr 323.06Cr 3.57TCr 333.75Cr 326.78Cr 13TCr | EV / Sales 2025 * |
4.87x | EV / Sales 2026 * | 4.66x |
| Free-Float |
97.91% | Yield 2025 * |
4.74% | Yield 2026 * | 5.08% |
More valuation ratios
* Estimated data
More news
Last Transcript: DRI Healthcare Trust
More press releases
| 1 day | +1.53% | ||
| 1 week | +3.34% | ||
| Current month | +4.42% | ||
| 1 month | +8.83% | ||
| 3 months | +23.17% | ||
| 6 months | +13.99% | ||
| Current year | +17.75% |
| 1 week | 13.3 |  | 14.18 |
| 1 month | 12.85 | | 14.18 |
| Current year | 10.7 | | 14.18 |
| 1 year | 10.7 | | 15.12 |
| 3 years | 6.64 | | 17.43 |
| 5 years | 5.83 | | 17.43 |
| 10 years | 5.83 | | 17.43 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gary Collins
CEO | Chief Executive Officer | 62 | 08/07/2024 |
Amit Kapur
DFI | Director of Finance/CFO | - | 16/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Collins
CHM | Chairman | 62 | 22/01/2021 |
Ali Hedayat
BRD | Director/Board Member | 50 | 01/06/2020 |
Kevin Layden
BRD | Director/Board Member | 65 | 22/01/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.53% | +3.34% | +18.25% | +74.12% | 56Cr | ||
| +0.47% | +1.46% | -15.21% | +139.25% | 71TCr | ||
| +0.90% | +1.37% | +7.24% | -11.55% | 38TCr | ||
| +2.30% | +2.23% | +16.04% | +27.58% | 34TCr | ||
| +2.82% | +3.18% | -52.84% | +14.03% | 31TCr | ||
| +1.15% | +1.11% | +7.52% | -18.30% | 26TCr | ||
| +1.70% | +0.79% | +2.18% | +19.88% | 24TCr | ||
| +2.55% | +2.27% | -11.03% | -3.78% | 22TCr | ||
| +0.37% | +1.98% | -33.34% | -9.44% | 21TCr | ||
| +1.30% | +1.19% | -4.92% | +20.88% | 16TCr | ||
| Average | +0.94% | +0.65% | -6.61% | +25.27% | 28.18TCr | |
| Weighted average by Cap. | +0.69% | +0.44% | -9.45% | +38.39% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 18Cr 16Cr 15Cr 13Cr 25Cr 1.57TCr 28Cr 173.65Cr 66Cr 733.95Cr 69Cr 67Cr 2.67TCr | 18Cr 15Cr 14Cr 13Cr 25Cr 1.55TCr 27Cr 172.08Cr 66Cr 727.34Cr 68Cr 67Cr 2.65TCr |
| Net income | 1.02Cr 87.46L 81.53L 75.36L 1.4Cr 88Cr 1.55Cr 9.72Cr 3.72Cr 41Cr 3.84Cr 3.76Cr 149.64Cr | 1.99Cr 1.7Cr 1.59Cr 1.47Cr 2.72Cr 170.95Cr 3.03Cr 19Cr 7.24Cr 80Cr 7.48Cr 7.33Cr 291.6Cr |
| Net Debt | 33Cr 28Cr 26Cr 24Cr 45Cr 2.83TCr 50Cr 313.94Cr 119.99Cr 1.33TCr 123.96Cr 121.38Cr 4.83TCr | 28Cr 24Cr 23Cr 21Cr 39Cr 2.44TCr 43Cr 270.31Cr 103.32Cr 1.14TCr 106.73Cr 104.51Cr 4.16TCr |
More financial data
* Estimated data
Employees
-
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/25/10 | 13.93 $ | +1.53% | 38,235 |
| 09/25/09 | 13.72 $ | -1.08% | 71,145 |
| 08/25/08 | 13.87 $ | +0.22% | 1,42,906 |
| 07/25/07 | 13.84 $ | +3.52% | 56,623 |
| 04/25/04 | 13.37 $ | +0.75% | 12,885 |
Delayed Quote Toronto S.E., July 11, 2025 at 01:29 am IST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
10.01USD
Average target price
13.75USD
Spread / Average Target
+37.28%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DHT.U Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition